PSMD1 and Huntington disease: Among the HD patients, the anti-S1 antibody titer in the breakthrough infection group (141,694 ± 76,265 AU/mL) was significantly higher than that in the booster immunization group (29,199 ± 74,998 AU/mL, p = 0.004).